Medical Illustration: Targeting HER2 in Gastric Cancer

For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
BY Erin Moore
PUBLISHED April 15, 2016
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
ILLUSTRATION BY ERIN MOORE
ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009
*HER2 is also associated with breast cancer.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Gastric Cancer CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In